FDA Will Conduct "National Search" For Head Of Oncology Office
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency formally announces creation of an Office of Oncology Drug Products. The new director will oversee the consolidation of three areas within the Center for Drug Evaluation & Research currently responsible for cancer drug reviews.
You may also be interested in...
FDA’s Pazdur Tapped For New Oncology Office Director
Oncology division head Pazdur is selected to lead FDA’s new Office of Oncology Drug Products following national search. Pazdur will begin assuming duties of the office May 1; the office will officially launch in July as part of a broader Office of New Drugs reorganization.
FDA’s Pazdur Tapped For New Oncology Office Director
Oncology division head Pazdur is selected to lead FDA’s new Office of Oncology Drug Products following national search. Pazdur will begin assuming duties of the office May 1; the office will officially launch in July as part of a broader Office of New Drugs reorganization.
FDA Oncology Office Director Will Be Selected In Next Few Weeks
The selection of a director for the new Office of Oncology Drug Products will be finalized in the next few weeks, FDA said